The Vanguard Group Discloses Interests in Bodycote plc, Revealing Market Position

The Vanguard Group, Inc. has disclosed its interests in Bodycote plc, revealing a considerable stake as per Form 8.3, dated 6 October 2026. The Group controls 9,303,980 ordinary shares, representing 5.47% of Bodycote’s relevant securities. This disclosure, under Rule 8.3 of the UK Takeover Code, reflects a key market position for Vanguard, indicating its significant influence in Bodycote.

Transaction activities include the purchase of 89 shares at 9.11 GBP and the sale of 1,440 shares at 9.10 GBP per unit, demonstrating active portfolio management. While there are no open positions involving derivatives or other agreements influencing Bodycote’s securities, these movements underscore Vanguard’s strategic investment approach.

With no indemnity agreements or option arrangements reported, the disclosure remains straightforward, emphasizing transparency in Vanguard's dealings with Bodycote plc. This positioning aligns with Vanguard’s broader investment strategy, monitoring and adjusting holdings in key market players.